78 FR 117 pgs. 36591-36594 - Importer of Controlled Substances;Notice of Application;Lipomed
Type: NOTICEVolume: 78Number: 117Pages: 36591 - 36594
FR document: [FR Doc. 2013-14446 Filed 6-17-13; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;Notice of Application;Lipomed
Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this is notice that on March 22, 2013, Lipomed, One Broadway, Cambridge, Massachusetts 02142, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances:
| Drug | Schedule |
|---|---|
| Cathinone (1235) | I |
| Methcathinone (1237) | I |
| 4-Mephedrone (1248) | I |
| N-Ethylamphetamine (1475) | I |
| N,N-Dimethylamphetamine (1480) | I |
| Fenethylline (1503) | I |
| Aminorex (1585) | I |
| 4-Methylaminorex (cis isomer) (1590) | I |
| Gamma Hydroxybutyric Acid (2010) | I |
| Methaqualone (2565) | I |
| Mecloqualone (2572) | I |
| JWH-250 (6250) | I |
| SR-18 (Also known as RCS-8) (7008) | I |
| JWH-019 (7019) | I |
| JWH-081 (7081) | I |
| SR-19 (Also known as RCS-4)(7104) | I |
| JWH-018 AND AM-678 (7118) | I |
| JWH-122 (7122) | I |
| JWH-073 (7173) | I |
| JWH-200 (7200) | I |
| AM-2201 (7201) | I |
| JWH-203 (7203) | I |
| Alpha-ethyltryptamine (7249) | I |
| Ibogaine (7260) | I |
| CP-47497 (7297) | I |
| CP-47497 C8 Homologue (7298) | I |
| Lysergic acid diethylamide (7315) | I |
| 2C-T-7 (7348) | I |
| Marihuana (7360) | I |
| Tetrahydrocannabinols (7370) | I |
| Parahexyl (7374) | I |
| Mescaline (7381) | I |
| 2C-T-2 (7385) | I |
| 3,4,5-Trimethoxyamphetamine (7390) | I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) | I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) | I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) | I |
| 2,5-Dimethoxyamphetamine (7396) | I |
| JWH-398 (7398) | I |
| 2,5-Dimethoxy-4-ethylamphetamine (7399) | I |
| 3,4-Methylenedioxyamphetamine (7400) | I |
| 5-Methoxy-3,4-methylenedioxyamphetamine(7401) | I |
| N-Hydroxy-3,4-methylenedioxyamphetaimine(7402) | I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) | I |
| 3,4-Methylenedioxymethamphetamine (7405) | I |
| 4-Methoxyamphetamine (7411) | I |
| 5-Methoxy-N-N-dimethyltryptamine (7431) | I |
| Alpha-methyltryptamine (7432) | I |
| Bufotenine (7433) | I |
| Psilocybin (7437) | I |
| Psilocyn (7438) | I |
| 5-Methoxy-N,N-diisopropyltryptamine (7439) | I |
| N-Ethyl-1-phenylcyclohexylamine (7455) | I |
| 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) | I |
| 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (7473) | I |
| N-Ethyl-3-piperidyl benzilate (7482) | I |
| N-Methyl-3-piperidyl benzilate (7484) | I |
| N-Benzylpiperazine (7493) | I |
| 2C-D (7508) | I |
| 2C-E (7509) | I |
| 2C-H (7517) | I |
| 2C-I (7518) | I |
| 2C-C (7519) | I |
| 2C-N (7521) | I |
| 2C-P (7524) | I |
| 2C-T-4 (7532) | I |
| MDPV (7535) | I |
| Methylone (7540) | I |
| AM-694 (7694) | I |
| Acetyldihydrocodeine (9051) | I |
| Benzylmorphine (9052) | I |
| Codeine-N-oxide (9053) | I |
| Cyprenorphine (9054) | I |
| Desomorphine (9055) | I |
| Etorphine (except HCI) (9056) | I |
| Codeine methylbromide (9070) | I |
| Dihydromorphine (9145) | I |
| Difenoxin (9168) | I |
| Heroin (9200) | I |
| Hydromorphinol (9301) | I |
| Methyldesorphine (9302) | I |
| Methyldihydromorphine (9304) | I |
| Morphine methylbromide (9305) | I |
| Morphine methylsulfonate (9306) | I |
| Morphine-N-oxide (9307) | I |
| Myrophine (9308) | I |
| Nicocodeine (9309) | I |
| Nicomorphine (9312) | I |
| Normorphine (9313) | I |
| Pholcodine (9314) | I |
| Thebacon (9315) | I |
| Acetorphine (9319) | I |
| Acetylmethadol (9601) | I |
| Allylprodine (9602) | I |
| Alphacetylmethadol except levo-alphacetyl-methadol (9603) | I |
| Alphamethadol (9605) | I |
| Dioxaphetyl butyrate (9621) | I |
| Dipipanone (9622) | I |
| Elhylmethylthiambutene (9623) | I |
| Etonitazene (9624) | I |
| Etoxeridine (9625) | I |
| Furethidine (9626) | I |
| Hydroxypethidine (9627) | I |
| Ketobemidone (9628) | I |
| Levomoramide (9629) | I |
| Levophenacylmorphan (9631) | I |
| Morpheridine (9632) | I |
| Noracymethadol (9633) | I |
| Norlevorphanol (9634) | I |
| Normethadone (9635) | I |
| Norpipanone (9636) | I |
| Phenadoxone (9637) | I |
| Phenampromide (9638) | I |
| Phenoperidine (9641) | I |
| Piritramide (9642) | I |
| Proheptazine (9643) | I |
| Properidine (9644) | I |
| Racemoramide (9645) | I |
| Trimeperidine (9646) | I |
| Phenomorphan (9647) | I |
| Propiram (9649) | I |
| Tilidine (9750) | I |
| Para-Flouorofentanyl (9812) | I |
| 3-Methylfentanyl (9813) | I |
| Acetyl-alpha-methylfentanyl (9815) | I |
| Beta-hydroxy-3-methylfentanyl (9831) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Lisdexamfetamine (1205) | II |
| Phenmetrazine (1631) | II |
| Methylphenidate (1724) | II |
| Amobarbital (2125) | II |
| Pentobarbital (2270) | II |
| Secobarbital (2315) | II |
| Glutethimide (2550) | II |
| Nabilone (7379) | II |
| 1-Phenylcyclohexylamine (7460) | II |
| Phencyclidine (7471) | II |
| 4-Anilino-N-phenethyl-4-piperidine (8333) | II |
| Phenylacetone (8501) | II |
| 1-Piperidinocyclohexanecarbonitrile (8603) | II |
| Alphaprodine (9010) | II |
| Anileridine (9020) | II |
| Cocaine (9041) | II |
| Codeine (9050) | II |
| Etorphine HCI (9059) | II |
| Dihydrocodeine (9120) | II |
| Oxycodone (9143) | II |
| Hydromorphone (9150) | II |
| Diphenoxylate (9170) | II |
| Ecgonine (9180) | II |
| Ethylmorphine (9190) | II |
| Hydrocodone (9193) | II |
| Levomethorphan (9210) | II |
| Levorphanol (9220) | II |
| Isomethadone (9226) | II |
| Meperidine (9230) | II |
| Meperidine intermediate-B (9233) | II |
| Metazocine (9240) | II |
| Methadone (9250) | II |
| Methadone intermediate (9254) | II |
| Metopon (9260) | II |
| Dextropropoxyphene, bulk(non-dosage forms) (9273) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Dihydroetorphine (9334) | II |
| Levo-alphacetylmethadol (9648) | II |
| Oxymorphone (9652) | II |
| Noroxymorphone (9668) | II |
| Phenazocine (9715) | II |
| Piminodine (9730) | II |
| Racemethorphan (9732) | II |
| Racemorphan (9733) | II |
| Alfentanil (9737) | II |
| Remifentanil (9739) | II |
| Sufentanil (9740) | II |
| Carfentanil (9743) | II |
| Tapentadol (9780) | II |
| Bezitramide (9800) | II |
| Fentanyl (9801) | II |
The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes.
Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedules I and II, which fall under the authority of section 1002(a)(2)(B) of the Act 21 U.S.C. 952 (a)(2)(B) may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 1316.47.
Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 18, 2013.
This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745-46, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, thatthe requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: June 7, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of Diversion Control,Drug Enforcement Administration.
[FR Doc. 2013-14446 Filed 6-17-13; 8:45 am]
BILLING CODE 4410-09-P